Fujirebio Diagnostics, Inc. (FDI), is a premier diagnostics company and the industry leader in the development of Tumor Marker assays. FDI specializes in the clinical development, manufacturing and commercialization of in vitro diagnostic products for the detection, prognosis, and monitoring of human disease states with an emphasis in Oncology. FDI utilizes its world wide distribution network to enable global access of our diagnostic products by physicians and patients.
As a satisfied Bassets client since 1999, Fujirebio Diagnostics, Inc. has benefited from many of the system enhancements over the years. Bassets allows for easy tracking and depreciation of all types of research equipment. These research specialists found the best solution to their fixed asset problem with Bassets.